Neurologic Manifestations of Hypoglycemia by William P. Neil & Thomas M. Hemmen
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
13 
Neurologic Manifestations of Hypoglycemia 
William P. Neil and Thomas M. Hemmen 
University of California, San Diego 
United States of America (USA) 
1. Introduction 
Unlike most other body tissues, the brain requires a continuous supply of glucose.  It has 
very limited endogenous glycogen stores, and does not produce glucose intrinsically.1 
Although it accounts for 2% of body weight, the brain utilizes 25% of the body’s glucose due 
to its high metabolic rate.2, 3 Evidence for the brains sole reliance on glucose came from 
obtaining a respiratory quotient of one after measuring differences between arterial and 
venous content of oxygen and carbon dioxide in blood traveling through the brain.4  
In the past, neurons were thought to directly metabolize glucose, however, more recent 
studies suggest astrocytes may play an important role in glucose metabolism.5 Astrocytic 
foot processes surround brain capillaries, which deliver glucose to the brain. With this, they 
form the first cellular barrier for entering glucose.5 Astrocytes contain the non-insulin 
dependent GLUT1 transporter, as well as the insulin dependent GLUT4 transporter, 
suggesting a possible role for astrocytes in regulating and storing brain glucose in an insulin 
dependent and independent manner (see figure 1).6-8 
In addition to glucose, the brain contains a very limited store of glycogen, (between 0.5 and 
1.5 g, or about 0.1% of total brain weight). Unlike peripheral tissue, where glycogen is 
readily mobilized during hypoglycemia, the brain can only function normally for a limited 
duration. Glycogen content seems to fall in areas of highest brain metabolic rate, suggesting 
at least some, albeit limited role as fuel during hypoglycemia.7   
Although the brain relies primarily on glucose during normal conditions, it can use ketone 
bodies during starvation. These ketone bodies cannot however meet all of the metabolic 
demands of the brain.9  
2. Pathophysiology  
The brain areas most vulnerable to hypoglycemia are (in order) the subiculum, small and 
medium sized caudate neurons, area CA1 of the hippocampus, the dentate gyrus and 
superficial cortical layers, specifically layers 2 and 3.10 Damage induced by hypoglycemia in 
the rat brain was not limited to a particular type of neuron, but those near the cerebrospinal 
fluid (CSF) spaces seemed to be more vulnerable.10 Similar distribution of injury was shown 
in autopsy of three human subjects with hypoglycemia.11  
Excitatory amino acids such as glutamate and aspartate were found in larger than normal 
quantities in the CSF space of hypoglycemic animals.12, 13 These increases occur as a result of 
less glucose as a substrate for the tricarboxylic acid (TCA) cycle during hypoglycemia. 
Lower glucose levels ultimately lead to lower acetate levels. This, in turn causes oxaloacetate  
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from Pellerin 1994 
Fig. 1. Schematic of the mechanism for glutamate-induced glycolysis in astrocytes during 
physiological activation. At glutamatergic synapses, glutamate depolarizes neurons by 
acting at specific receptor subtypes. The action of glutamate is terminated by an efficient 
glutamate uptake system located primarily in astrocytes. Glutamate is cotransported with 
Na+, resulting in an increase in[Na+]i, leading to activation of Na+/K+-ATPase. The pump, 
fuled by ATP provided by membrane-bound glycolytic enzymes[possibly phosphoglycerate 
kinase(PGK); see ref. 22], activates glycolysis-i.e., glucose utilization and lactate production-
in astrocytes. Lactate, once released, can bi taken up by neurons and serve as an adequate 
energy substrate. For graphic clarity, only lactate uptake into presynaptic terminals is 
indicated. However, this process  could also occur at the postsynaptic neuron. Based on 
recent evidence, glutamate receptors are also shown on astrocytes(12). This model, which 
summarizes in vitro experimental evidence indicating glutamate-induced glycolysis, is 
taken to reflect cellular and molecular events occurring during activation of a given cortical 
area[arrow labeled A(activation)]. Direct glucose uptake into neurons under basal 
conditions is also shown[arrow labeled B(basal conditions)]. Pyr, pyruvate; Lac, lactate; Gln, 
glutamine; G, guanine nucleotide binding protein. 
to form aspartate, and  ketoglutarate to form glutamate (see figure 2).14, 15 Glutamate and 
aspartate build up in the tissue, then interstitial space and ultimately CSF space.12 These 
findings suggest the possibility of an excitotoxic agent rather than insufficient glucose 
substrate as a cause for neuronal dysfunction and death during hypoglycemia.10 
Glutamate and aspartate cause sustained glutamate receptor activation, particularly at the 
NMDA receptor.16-19 The excess glutamate and aspartate activation leads initially to sodium 
and water influx which causes cellular edema.20 This is followed by calcium (an important 
neuronal second messenger) influx into the cells, which causes dysfunction of many 
intracellular processes.21-24 NMDA receptor activation leads to the production of reactive 
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oxygen species which damage neuronal DNA.25 The DNA damage in turn activates poly 
(ADP-ribose) polymerase-1 (PARP-1). Under normal conditions, PARP-1 acts to repair 
DNA, but with extensive damage, it can increase apoptosis inducing factor and stimulate 
cell death (see figure 3).26, 27 Hypoglycemic neuronal death can be halted by severing 
glutamatergic axons, or by blocking glutamate receptors in animals.17, 18 
 
 
 
 
 
from  Sutherland 2008 
 
 
Fig. 2. Truncation of the Krebs Cycle during Hypoglycemia. Adapted from Sutherland: 
Medicinal Chemistry , 2008, 4; 379-85 
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from Suh 2007 
Key aspects of hypoglycemia-induced neuronal death. (1) Neuronal depolarization is induced by 
hypoglycemia. (2) Depolarization leads to release of glutamate, aspartate, and zinc. Impaired astrocyte 
uptake may contribute to increased glutamate extracellular levels. (3) Glutamate receptor activation and 
zinc influx induce production of reactive oxygen species (ROS) from mitochondria or NADPH oxidase, 
subsequent DNA damage and activation of poly(ADP-ribose) polymerase-1 (PARP-1), mitochondrial 
permeability transition (MPT), and cell death. 
Fig. 3. Key Aspects of Hypoglycemia induced Neuronal Cell Death. From Suh : Glia55:1280–
1286 (2007)  
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3. Clinical manifestations 
Neuronal function is known to worsen at lower levels of blood glucose. Under normal 
conditions, endogenous insulin secretion ceases at levels of around 4.5mmol/l (81 mg/dL). 
Counterregulatory hormones such as glucagon and epinephrine are later secreted in 
response to a fall in blood glucose to 3.8 mmol/l (68 mg/dL). This causes autonomic 
symptoms such as sweating, irritability and tremulousness.  At 2.8 mmol/l (50 mg / dl) 
profound neurologlycopenic symptoms such as seizure, cognitive disturbance and 
confusion occur.  Below this level coma appears, electroencephalogram (EEG) becomes flat, 
and neuron death occurs below 1 mmol/L (18 mmol/dL)(see figure 4).1 
Hypoglycemia has been recognized as a clinical syndrome since 1924.28 In 1985, Malouf and 
Brust  evaluated 125 patients with hypoglycemia presenting to a local hospital over a one 
year period.29Among their study cohort, sixty-five patients were obtunded, stuporous, or 
comatose. Another 38 had confusion or “bizarre” behavior, 10 were dizzy or tremulous, 9 
had seizures, and 3 had hemiparesis. Diabetes mellitus, alcoholism, and sepsis, alone or in 
combination, accounted for 90% of predisposing conditions. Death occurred in 11%, but was 
only attributed directly to hypoglycemia in one patient. Four patients had residual 
neurologic symptoms after resolution of hypoglycemia.29  
The neurological manifestations of thirty patients with hypoglycemia from insulinoma were 
described by Daggett and Nabarro.30 They found that the most common presentation was 
confusion (20 cases), followed by coma (16 cases), seizures (8 cases) and weakness (8 
cases).30 Their review included information about 220 other patients with hypoglycemia and 
insulinoma from 7 series. Among these, 152 cases had confusion, 82 had coma, 58 had 
seizures, 18 had headache, and 6 had weakness.30  
Recurrent exposure to hypoglycemia, particularly in insulin treated type 1 diabetes, but to a 
lesser extent in type 2 diabetes can chronically impair the counterregulatory response to 
hypoglycemia. Two recognized syndromes are hypoglycemia associated autonomic failure 
(HAAF), and impaired awareness of hypoglycemia (IAH). After 20 years, around half of 
patients with type 1 diabetes have an impaired response of glucagon and epinephrine to 
hypoglycemia.31 Likely as a result of the blunted epinephrine response, IAH develops, as 
there are less of the typical clinical manifestations from epinephrine such as sweating and 
tremors.32  
Various other neurological manifestations of hypoglycemia have been described. These 
include headache, cognitive disturbance, hemiplegia, coma, and seizures.  
4. Headache 
Since 1933, fasting and hunger have been understood to precipitate migraine attacks.33-36 
One of the largest studies to demonstrate fasting as a migraine precipitant included 1883 
patients who responded to a questionnaire regarding dietary habits in the 24 hours before 
the migraine. Fasting was found to be a precipitating factor in 67% of patients.37 
A headache as a direct result of fasting, and without the autonomic features of migraine has 
been described.38 It is usually diffuse, nonpulsatile of moderate intensity, and should occur 
16 hours after fasting, with resolution within 72 hours of food intake (see table 1). The 
lifetime prevalence of this type of headache is estimated to be 4.1%.39 
Various other headache types have been attributable to fasting for religious reasons, and 
come under various names such as Yom Kippur Headache and Ramadan Headache. A study 
 
www.intechopen.com
 Diabetes – Damages and Treatments 
 
264 
 
from Cryer, 2007 
Fig. 4. Sequence of responses to falling arterial plasma glucose concentrations. The solid 
horizontal line indicates the mean and the dashed horizontal lines the upper and lower 
limits of physiological postabsorptive plasma glucoseconcentrations in humans. The 
glycemic thresholds for decrements in insulin secretion, increments in glucagon and 
epinephrine secretion, symptoms, and decrements in cognition. Have been defined in 
healthy humans (1) (see text). Those for seizure and coma and for neuronal death are 
extrapolated from clinical observations of humans (9) and studies in monkeys (12) as well as 
in other experimental animals (13–15). In this issue of the JCI, Suh and colleagues (13) report 
that glucose reperfusion increased brain neuronal death in their rodent model of profound 
hypoglycemia. 
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Diagnostic criteria for headache attributed to fasting 
(code 10.5) 
 
A. Headache with at least one of the following characteristics and  
fulfilling criteria C and D: 
1. Frontal location 
2. Diffuse pain 
3. Non-pulsating quality 
4. Mild or moderate intensity 
B. The patient has fasted for >16 h 
C. Headache develops during fasting 
D. Headache resolves within 72 h after resumption of food intake 
Table 1. International HA classification 
comparing 211 patients who observed a total fast for 25 hours during Yom Kippur to 136 
patients who did not found 82 (39%) of the fasters complained of headache compared to 7% 
of non-fasters.40 Although abstinence from caffeine and nicotine was observed in the fasting 
group, this did not appear to have an influence on headache. A questionnaire given to 91 
participants who had observed a complete fast on the first day of Ramadan and 25 who had 
not found 41% of the fasting group complained of headache, compared to only 8% in the 
control group (p=0.002).41 Although two of the subjects developed headache shortly after 
their last meal, suggesting to the author a possibility of reactive hypoglycemia, most of the 
headaches were attributable to caffeine withdrawal. Hypoglycemia was not formally 
evaluated in these studies. 
Blau and Cumings attempted to identify a correlation between blood glucose and migraine. 
They had 12 migraine subjects fast for 19 hours, and measured blood sugar levels at regular 
intervals. Six of these subjects developed migraine, at an average of 11 to 14 hours after the 
beginning of the fast. The lowest blood sugar levels varied from 44 to 77 mg/dl.42 
Pearce recorded serial blood glucose levels in 20 migraine patients, and 10 matched controls 
after injecting 0.15 units/kg body weight of insulin. Thirty minutes after the infusion, 
migraine patients had an average blood glucose level of 20.4 mg/dl. After 2 hours of 
observation, only one (5%) of the migraine patients developed a headache, and one (5%) 
developed aura without headache. None of the control subjects developed headache, and 
most patients complained of mild faintness, sweating and palpitations. The author 
concluded that hypoglycemia may be implicated only in a minority of migraine patients, 
and that more  complex metabolic factors are likely implicated.34 
5. Cognitive disturbance and dementia 
Hypoglycemia can affect cognitive performance and learning acutely. There are well 
documented reports and experimental trials linking various cognitive disturbances with 
hypoglycemia. A link between long term development of dementia and repeated 
hypoglycemia is more controversial. 
Memory and learning was tested among thirty-six type 1diabetics during an episode of 
controlled hypoglycemia with a target blood glucose of 2.5 mmol/l for 60 minutes. Subjects 
attempted to memorize instructions during euglycemia and recall was assessed during 
hypoglycemia. Word recall, story recall, visual recall was also assessed during 
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hypoglycemia. Euglycemia was then restored and delayed memory for the conventional 
tasks was tested. Euglycaemic control subjects performed the same tasks at blood glucose of 
4.5 mmol/l. Hypoglycemia impaired performance on the prospective memory task 
(p=0.004) as well as both immediate and delayed recall for the word (p<0.01) and story 
recall tasks (p<0.01). No difference was found among subject with normal or impaired 
glycemic awareness. There was no significant change on the visual memory task.43 
McCrimmon et. Al. found diminished visual processing speed despite normal visual acuity 
in 20 non-diabetic subjects during controlled hypoglycemia.44 Significant reductions in 
speed of naming and labeling skills at hypoglycemia without associated impairment in 
accuracy has been observed.45  Immediate and delayed memory were impaired in 16 type 1 
diabetic patients during controlled hypoglycemia of 2.5 mmol/l as assessed by the Trail 
Making B Test, and the Digit Symbol Test.46 Similar tests have shown impairment in visuo-
spatial ability during hypoglycemia.47  
Tests of sensory perceptual processing, simple motor abilities, attention, learning, memory, 
language, and spatial and constructional abilities at plasma glucose levels of 2.2 mmol/l 
were diminished when compared to basal levels of performance at 8.9 mmol/L among 42 
type 1 diabetics. Tests involving associative learning, attention, and mental flexibility were 
the most affected.48 Others have shown similar disruptions in various cognitive domains 
during hypoglycemia, leading to little doubt of the acute effects of hypoglycemia on 
cognition.49 
The role of hypoglycemic episodes on long term cognitive outcomes, and development of 
dementia is however more controversial. The 2007 Diabetes Control and Complications Trial 
(DCCT) and its follow-up Epidemiology of Diabetes Interventions and Complications 
(EDIC) followed 1144 diabetic patients for an average of 18 years.50 Forty percent of these 
patients reported at least one episode of hypoglycemic seizure or coma. Despite this, there 
was no associated decline in any cognitive domain. Those with elevated glycated 
hemoglobin had moderate declines in motor speed (P=0.001) and psychomotor efficiency 
(P<0.001).50 
More recently, a longitudinal cohort of 16,667 patients showed a greater risk of dementia 
among those with hypoglycemic episodes, with an attributable risk of dementia   of  2.39% 
per year (95% CI 1.72%-3.01%).51  This study was limited in that it was a retrospective 
review of electronic medical records. Furthermore, reverse causation may account for the 
association. Patients with dementia may have been more likely to have irregular food intake 
and make dosing errors in their glycemic medications. Further trials are needed to 
investigate a possible association between hypoglycemia and long term cognition.  
6. Hypoglycemic hemiplegia 
The clinical syndrome of hypoglycemic hemiplegia has been recognized for over 50 years.52, 53 
It appears to be rare, with case series reporting an incidence of  2% among those admitted with 
hypoglycemia.29 Objective weakness was found in 7 patients with hypoglycemia from 
insulinoma; 3 had hemiparesis, 2 had paraparesis and 2 had  monoparesis. On average the 
weakness resolved over a period of 1 hr to 3 days once normoglycaemia was maintained.29, 30 
Wallis et. al. reviewed 16 patients presenting with weakness and blood glucose of less than 
45 mg/dl.54 Most patients were initially misdiagnosed as stroke, all but one were conscious 
during the attack, four had associated aphasia, most (12/16) had right sided weakness and 
all had resolution without recurrence within 15 minutes of glucose infusion. One of the 
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patients had a total of four episodes of transient hemiplegia before hypoglycemia was 
diagnosed. He was left with permanent dysarthria and ataxia. One patient died after 
multiple recurrent hypoglycemic episodes and subsequent deep coma related to insulinoma. 
Autopsy of this patient showed diffuse cortical injury, but no focal lesions.54 
Another review involving 29 patients found 72% were caused by insulin treatment, and 
mean serum glucose was 35 mg/dL. Most (78%) had recurrent attacks, and on average 3.5 
attacks occurred before a diagnosis of hypoglycemic hemiparesis was made. Interestingly, 
the  majority of patients (72%) had right sided weakness, most with aphasia.55  
Hypoglycemia must be excluded in a patient presenting with symptoms consistent with 
transient ischemic attack or stroke. Current guidelines for the treatment of stroke patients with 
IV tissue plasminogen activator exclude those with a glucose level below 50 mg/dL if their 
symptoms are likely attributable to the hypoglycemia.56 This presentation is however much 
more rare than ischemic stroke. During a one year period, three patients were admitted with 
hypoglycemic hemiplegia compared to 400 with ischemic stroke in an urban hospital.29 
 
 
From Botcher 2005 
Fig. 5. A, Initial DWI (repetition time/echo time/_ 4100/96/90;__1000 s/mm2; field of view 
230 mm; matrix: 128_128) with increased signal intensities in bilateral corona radiata and 
splenium. B, Initial ADC maps with signal reduction also in bilateral corona radiata and 
splenium corresponding to DWI images. 
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Reports suggest that brain imaging during hypoglycemic hemiplegia, and coma may be 
similar to that observed during ischemic stroke. Specifically, in the setting of ischemic 
stroke, MRI shows restricted diffusion of water molecules due to ionic pump failure. This 
leads to restriction on diffusion weighted imaging (DWI) and prolongation of apparent 
diffusion coefficient (ADC).  ADC changes were found to occur in association with the onset 
of EEG isoelectricity in insulin induced hypoglycemic rats.57 
Case reports have shown ADC and DWI changes in patients with hypoglycemic hemiplegia. 
These changes usually reverse after clinical improvement with glucose recussitation.58-60 
Unlike ischemic stroke, hypoglycemic changes on MRI are often bilateral, affect the cortex, 
hippocampus and basal ganglia, and do not necessarily correspond to a vascular 
territory(see figure 5).61  
Although hypoglycemic hemiplegia is initially clinically indistinguishable from an ischemic 
stroke, the pathophysiology is likely different. Autopsy studies have not demonstrated 
lesions in vascular territories, but rather diffuse damage.11, 54 Hypoglycemia has been shown 
to produce vasodilatation in animals, unlike vasoconstriction seen in stroke.62 Although case 
reports have shown patients with hypoglycemic hemiplegia and associated carotid artery 
stenosis, most others have not validated this observation.54, 55, 63 The notion of underlying 
cerebrovascular disease as a cause for hypoglycemic hemiplegia does not seem to be 
supported. 
Profound hypoglycemia causes tissue alkalosis resulting from ammonia formation and 
consumption of metabolic acids, unlike tissue acidosis seen in cerebral ischemia.64 
Hypoglycemic brain death preferentially affects neurons, whereas ischemia tends to affect 
glial and endothelial cells as well.65 Hypoglycemia generally spares axons while damage 
from ischemia affects all parts of the neuron.66 
7. Hypoglycemic coma 
One of the most feared, and occasionally devastating effects of hypoglycemia is coma. The 
relationship between insulin treatment and coma was first recognized by Sakel in the 
1930s.67 He and others noticed that when treating schizophrenics with insulin (a now 
abandoned practice), a duration of treatment under 30 minutes allowed the patients to 
recover from the coma, but much longer, the coma would be irreversible.67, 68 Insulin 
induced hypoglycemia to a level of 0.7 mmol/l (13 mg/dl) was found to produce significant 
brain damage after 5-6 hours in monkeys. 69  
A retrospective analysis over a 7 year period evaluated 102 patients admitted with coma and 
blood glucose of below 49 mg/dL, and improvement with glucose administration. Most 
patients were type 2 diabetics (92/102) taking glycemic agents. Risk factors included age 
over 60, renal dysfunction decreased energy intake or infection. Sixty two patients 
responded within 12 hours of treatment, while the others had no resolution for up to 72 
hours. Death occur in 5 patients(4.9%).70 
A prospective one year study found sixty five of 125 (52%) admissions for hypoglycemia 
presented with obtundation, stupor or coma.29 While the length of time in coma could not 
always be determined, the one death related to hypoglycemia occurred in a patient with 
coma lasting over 20 hours. Of the 11 patients determined to be comatose for 12 hours or 
more, 10 remained comatose. Blood glucose level did not predict coma, as there was a wide 
range of blood glucose levels among these comatose patients, and similar results in those 
without coma.29 
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MR images of those in persistent vegetative state from hypoglycemia revealed lesions in the 
bilateral basal ganglia, cerebral cortex, substantia nigra, and hippocampus, which suggests 
the particular vulnerability of these areas.61 Involvement of the basal ganglia seems to 
portend a worse outcome, though evidence is limited to case reports.71 
Two markers of neuronal injury, NSE and S-100 may predict death or otherwise poor 
outcome in profound hypoglycemic coma. They showed no change in diabetics with mild 
hypoglycemic episodes, but were markedly elevated in 3 patients who died from 
hypoglycemic brain injury.72, 73 The disappearance of EEG activity is a prerequisite for 
hypoglycemia induced brain damage.66 
8. Seizures 
In autopsy studies, the cortex and hippocampus were most frequently involved in 
hypoglycemic brain damage.11 These areas are also commonly involved in seizures from 
other causes. 
In a prospective study of symptomatic hypoglycemia admissions over one year, 9 of 125 
(7.2%) patients presented with seizures related to hypoglycemia. Among the 9 seizure 
patients, 3 had comorbid epilepsy, and 6 were intoxicated with alcohol. The majority of the 
seizures were generalized tonic clonic, most recurred, and one patient had status 
epilepticus.29  
The landmark Diabetes Control and Complications Trial found 16  episodes of coma or 
seizure per 100 patient-years in the aggressive glucose control group, compared to 5 in the 
moderate control group.74 Another prospective study had a rate of severe events (the 
combination of seizure or coma) at 4.8/100 patient-years. Most of the severe events were 
seizures, and risk factors were age under 6 and glycosalated hemoglobin <7%.75 
A prospective study of 1382 patients with new onset seizures found that hypoglycemia was 
never found to be the inciting cause.76 This apparent discrepancy may be due to the fact that 
serum glucose was drawn after dextrose was given to presenting patients. Furthermore, this 
study focused on all those presenting with seizures, indicating hypoglycemia leading to 
seizures may be a rare event in non-diabetics. 
The NLSTEPSS study evaluated causes of status epilepticus in children, and found 4% were 
from metabolic causes.77 Metabolic causes of status epilepticus were found in 11% of adult 
patients.78 Unfortunately, these studies did not separate blood glucose from other metabolic 
causes.78 
Quantitative EEG recordings have shown that epileptiform activity (spikes) occurred at 
higher blood glucose levels in diabetic than non-diabetic children, and overall, occurred at 
higher glucose levels in children(3mmol/l) compared with adults (2 mmol/l)(see figure 6).79, 
80 In a case review of four children wearing a continuous glucose monitor, hypoglycemia 
occurred on average 2-4 hours before seizure onset.73 
During hypoglycemia, multiple metabolic derangements occur. In particular, the excitatory 
amino acids glutamate and aspartate increase out of proportion to a slight rise in 
extracellurlar GABA. The resulting brain excitatory milieu may account for seizure 
activity.64 
Investigators showed that fasting and insulin infusion in rats increased the incidence of 
barrel rotations, which is a characteristic phenotype of hypoglycemic seizures in the animal. 
In particular, they showed a decreased release of GABA in the substantia nigra pars 
reticulate in rats with  seizures.81 
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Fig. 6. Plasma glucose levels (mean SEM) during the hypoglycemic clamp, and 
approximate time at EEG regis- trations, in the 19 diabetic (solid circles) and 17 non-diabetic 
children (open circles) Bjorgaas 1998 
9. Conclusion 
Hypoglycemia has profound effects on the brain. At the cellular level, energy failure and 
excitotoxicity lead to interruptions of many critical cellular activities. Clinically, this can 
manifest as headache, seizure, stroke-like episodes, cognitive dysfunction, and coma. 
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